IPNP SEMINAR Thursday, October 9th, 2025, 12:00pm, Dr. Pierre-Pascal LENCK-SANTINI: Function of GABAergic Interneurons in the Neonatal Hippocampus Revealed by Optotagging in vivo


Seminar 2025
 
Thursday, October 9th, 2025, noon
Room D Levy, 102-108 rue de la santé - 75014 Paris
Dr. Pierre-Pascal LENCK-SANTINI
Institut de Biologie de la Méditerranée, Université Aix-Marseille, France

Function of GABAergic
Interneurons in the Neonatal
Hippocampus Revealed by
Optotagging in vivo


Host A Pierani

There is now long-lasting evidence that the construction and maturation of cortical networks during
development is activity dependent. In the developing hippocampus, such activity consists of
intermittent busts of activity called early sharp waves (eSPWs) that are spontaneously triggered in the
periphery. With age, eSPWs leave place to a continuous activity regimen dominated by rhythmic
activity. Pioneering ex-vivo experiments suggest that GABAergic interneurons control and
orchestrate immature network activity. In-vivo, however, this role is less clear. While there is evidence
for the recruitment of GABAergic neurons during eSPWs, the precise timing of their activation in
unknown. Furthermore, there are still uncertainties on how GABAergic cells impact the excitability of
the immature hippocampal networks in-vivo. To address these issues, we developed a
combined electrophysiological and optogenetic method allowing us to identify and manipulate
GABAergic neuron activity in neonatal mice. Our results show that GABAergic neurons were more
active than the rest of the recorded population and participated in more eSPWs. We also found
evidence of both spontaneous and GABA-driven inhibition as early as post-natal day (P) 3. This
inhibitory effect increased with age and reached plateau at P9-P10. Putative excitatory effect of
GABAergic firing was negligible. We propose that rather than being caused by a switch in the polarity
of GABA action, such rise of inhibition is due to the rapid growth of peri-somatic GABAergic inputs to
pyramidal cells. The resulting development of feed-back inhibition within hippocampal networks
would allow for the apparition of continuous network dynamics, ultimately supporting the
emergence of cognitive processes.

Stay tuned

This part of the website could either be in French or English, depending on the sources of the actualities.

Autres Séminaires

 01 janvier 2025 06 décembre 2025
Psychiatry and Neuroscience Seminar Series 2025
 06 février 2026
IPNP SEMINAR FRIDAY February 6th NOON, Dr. Stéphanie LENCK Institut du Cerveau - Paris : Cerebral venous blood flow regulates intracerebral pressure and fluid homeostasis via meningeal lymphatics
 17 février 2026
12h30 de la recherche -17 Février RDC CAFETERIA IPNP
 06 mars 2026 06 février 2026
IPNP SEMINAR FRIDAY March 6th NOON, Dr. Laure VERRET Centre de Biologie Intégrative (CBI) - Toulouse : The role of hippocampal parvalbumin neurons in memory deficits and functional recovery in Alzheimer’s models
 09 mars 2026
IPNP Seminar Monday, March 9th 2026, 2pm, Dr Xavier Bonnefont; Circadian plasticity in health and disease: the clock beyond clock genes
 26 mai 2026
12h30 de la recherche -26 mai 2026 Anorexie Mentale soins cliniques et biomarqueursRDC CAFETERIA IPNP
 05 juin 2026
IPNP SEMINAR FRIDAY June 5th NOON, Dr David Brody (USUHS – Bethesda, USA): Modular Engineering of Brain Imaging Molecular Contrast Agents Using anti-Transferrin Receptor Nanobodies for Blood Brain Barrier Transcytosis
 05 juin 2026 25 septembre 2026
IPNP Seminar Every friday Noon
 04 septembre 2026
IPNP SEMINAR FRIDAY September 4th NOON, Dr. Valérie Compan, Institut Universitaire de France, Nîmes Université: From Brain Circuits to Exhaled Biomarkers: Toward Preventive Neuropsychiatry in Adolescents
 29 septembre 2026
12h30 de la recherche -29 septembre 2026 Sclérose en plaques : remyéliniser grâce à l’activité électrique RDC CAFETERIA IPNP
 05 octobre 2026
IPNP SEMINAR MONDAY October 5th NOON, Dr. David Rubinsztein, University of Cambridge, UK: Strategies for enhancing toxic protein clearance in neurodegenerative diseases